Kalaris Therapeutics (KLRS) Accounts Payables (2019 - 2026)
Kalaris Therapeutics (KLRS) reported Accounts Payables of $1.12 million for Q2 2026, down 69.5% from $3.68 million a year earlier but up 24.2% from the prior quarter.
Kalaris Therapeutics (KLRS) Accounts Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, Kalaris Therapeutics posted Accounts Payables of $1.28 million, down 17.9% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of 5.9% (FY2020 to FY2025).
- By year, Accounts Payables came in at $1.56 million in FY2024 (-76.9%), $6.76 million in FY2023 (+125.1%), $3 million in FY2022 (-64.1%) and $8.36 million in FY2021 (+768.2%).
- Five-year quarterly Accounts Payables spans a low of $51,000 in Q3 2024 and a high of $8.36 million in Q4 2021.
- Year over year, Accounts Payables has now declined in each of the last three quarters, with growth averaging 107.7% over the last seven quarters.
- The high point for year-over-year Accounts Payables in five years was Q3 2025 (growth of 868.6%); the low point was Q3 2024 (a decline of 98.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $905,000 (Q1 2026), $1.28 million (Q4 2025) and $494,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Kalaris Therapeutics | 68.80 Mn | 68.80 Mn | - | 1.12 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 905,000.00 |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 494,000.00 |
| Jun 30, 2025 | 3.68 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 110,000.00 |
| Mar 31, 2024 | 765,000.00 |
| Dec 31, 2023 | 6.76 Mn |
| Sep 30, 2023 | 3.93 Mn |
| Jun 30, 2023 | 5.16 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 4.89 Mn |
| Jun 30, 2022 | 5.52 Mn |
| Mar 31, 2022 | 4.47 Mn |
| Dec 31, 2021 | 8.36 Mn |
| Sep 30, 2021 | 133,000.00 |
Kalaris Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=KLRS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();